Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2015-09-10 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Mauna Kea Technologies : le Cellvizio permet aux chirurgiens et aux anatomopathologistes d’évaluer avec précision et en temps réel les caractéristiques du cancer du sein
Regulatory Filings Classification · 90% confidence The document is a press release dated September 10, 2015, announcing the publication of clinical study results regarding the use of the company's Cellvizio technology in breast cancer surgery. It details scientific findings, quotes researchers, and mentions future press releases (like the Q3 2015 revenue announcement). This content structure—announcing news, study results, and corporate updates via a press release format—does not fit the specific definitions for 10-K, AR, ER, IR, or IP. Since it is a general corporate announcement detailing scientific progress and market relevance, and it is not a formal regulatory filing like a 10-K or a specific financial report, it best fits the general 'Regulatory Filings' fallback category (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but given the format, RNS is the most appropriate catch-all for non-standard, news-driven corporate disclosures that aren't earnings or formal reports.
2015-09-10 French
Mauna Kea Technologies annonce ses résultats du S1 2015
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for the first half (S1) of 2015, containing comprehensive financial statements (income statement, operational data, cash flow, and balance sheet metrics) and management's analysis of the results. It is not a mere announcement of a report, as it provides substantive financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report (IR). H1 2015
2015-09-09 French
Mauna Kea Technologies announces first half 2015 financial results
Interim / Quarterly Report Classification · 95% confidence The document is a press release from Mauna Kea Technologies announcing its financial results for the first half of 2015. It contains detailed financial tables (income statement data), management commentary, and operational highlights. Since it provides comprehensive financial data for an interim period (H1 2015) and is not merely an announcement of a report's availability, it is classified as an Interim/Quarterly Report. H2 2015
2015-09-09 English
Mauna Kea Technologies annonce le marquage CE pour sa nouvelle plateforme de navigation endomicroscopique infrarouge pour la chirurgie minimalement invasive
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies dated July 22, 2015, announcing the receipt of the CE marking for its new Cellvizio 800 platform. This announcement pertains to a regulatory approval for a medical device, which is a specific type of corporate update. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). Since it is an announcement regarding a regulatory milestone (CE marking), it fits best under the general category for regulatory announcements that aren't specifically about insider trading, delisting, or major shareholding changes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific regulatory approval announcement that doesn't fit the other specialized categories like Director's Dealing or Delisting. It is not a full Audit Report (AR) or a general Investor Presentation (IP).
2015-07-22 French
Mauna Kea Technologies announces CE mark for its novel near-infrared platform for endomicroscopic navigation during minimally invasive surgery
Regulatory Filings Classification · 95% confidence The document is a press release dated July 22, 2015, announcing that Mauna Kea Technologies has received CE mark approval for its Cellvizio 800 platform. This is a specific, material event announcement concerning regulatory clearance for a medical device. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a transcript (CT). Since it is a specific announcement of a regulatory/product milestone that doesn't fit the definitions for DVA, DLST, DIRS, DIV, etc., the most appropriate general category for significant, non-financial regulatory news that isn't a full legal proceeding report (LTR) is the general 'Regulatory Filings' (RNS) category, as it serves as the best fit for miscellaneous regulatory updates that aren't explicitly covered elsewhere, although it is a specific regulatory achievement announcement. Given the options, RNS is the best fit for a general regulatory announcement that isn't a standard financial filing or a specific legal/director action.
2015-07-22 English
Mauna Kea Technologies annonce son chiffre d’affaires du deuxième trimestre 2015
Earnings Release Classification · 98% confidence The document is titled "MAUNA KEA TECHNOLOGIES ANNONCE SON CHIFFRE D'AFFAIRES DU DEUXIEME TRIMESTRE 2015" (Mauna Kea Technologies announces its revenue for the second quarter of 2015). It provides detailed financial figures for the second quarter (T2 2015) and the first half (S1 2015), including revenue tables, commentary on regional performance, and cash position. This content structure—announcing period-specific financial results with key highlights and commentary—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a full Interim/Quarterly Report (IR) which would typically be filed with regulatory bodies like the SEC, but rather the initial public announcement of the results. Q2 2015
2015-07-15 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.